ARTICLES BY THIS AUTHOR
- 3/11/2024
Tackling the FP crisis
Two physician senators argue practice-ready assessment programs are a good tool to get IMGs into practice relatively quickly. - 3/11/2024
South Korea criticizes senior doctors for threatening to resign to support their juniors’ walkouts
About 12,000 junior doctors in South Korea have been off the job for a month. - 3/11/2024
My tips on how to avoid burnout as a surgeon
Physicians of all stripes are highly susceptible to burnout—but what should surgeons specifically do to protect themselves? - 3/11/2024
‘Absurdly common’: Physicians need to be more proactive about iron deficiency
The lab threshold for flagging iron deficiency ‘inappropriately low’ says one hematologist. - 3/10/2024
N.S. sexual health clinic can no longer give free birth control to patients in need
Dr. Lianne Yoshida says that for years the clinic has been using donations to provide contraceptive implant and intrauterine devices. - 3/10/2024
MedsChecks by pharmacies: Interrupting family doctors while getting paid twice as much
Every fax. A piece of paper. Every message. Each of these costs family doctors time and resources. - 3/10/2024
Surrey, B.C., hospital to get critical care tower with acute, specialized services
The premier says the province is at stage where it will soon start asking for feedback from health professionals who work at the hospital. - 3/10/2024
Undetectable = Untransmittable: A conversation between Dr. Theresa Tam and HIV activist Jade Elektra
Dr. Theresa Tam, Canada’s chief public health officer discusses the successes and limitations of a public health campaign with Jade Elektra, HIV Activist, drag performer and community builder. - 3/10/2024
Maker of much-debated ALS drug says it may stop selling it after study showed it didn’t work
The U.S. FDA approved Amylyx Pharmaceuticals’ Relyvrio in September 2022, following a years-long advocacy campaign by patients with amyotrophic lateral sclerosis, or ALS, a fatal muscle-wasting disease.